Talima Raises $19 Million

Talima Therapeutics Inc., a Santa Clara, Calif.-based developer of micro-implant technology for site-specific drug delivery, has raised $19 million in second-round funding. U.S. Venture Partners and Latterell Venture Partners co-led the deal, and were joined by return backers De Novo Ventures and Palo Alto Healthcare. Talima raised a $2 million Series A round in 2005 at a $5 million post-money valuation. www.talima.com